Amentoflavone Inhibits Metastatic Potential Through Suppression of ERK/NF-κB Activation in Osteosarcoma U2OS Cells
- PMID: 28870912
- DOI: 10.21873/anticanres.11900
Amentoflavone Inhibits Metastatic Potential Through Suppression of ERK/NF-κB Activation in Osteosarcoma U2OS Cells
Abstract
The study goal was to investigate effect of amentoflavone on nuclear factor-κB (NF-κB)-modulated metastatic mechanism in osteosarcoma U2OS cells. U2OS cells were treated with amentoflavone, NF-κB inhibitor, protein kinase B (PKB or AKT) inhibitor or mitogen-activated protein kinase (MAPK) inhibitor. Change of cell viability, NF-κB activation, expression of metastasis-associated proteins, signal transduction, and cell migration and invasion were evaluated by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, NF-κB reporter gene assay, western blotting, and cell migration and invasion assays. The results demonstrated that inhibition of activation of extracellular signal-regulated kinases (ERK) was a key point for suppression of NF-κB-modulated metastatic mechanism. Amentoflavone significantly inhibited NF-κB activation, ERK phosphorylation, expression of metastasis-associated proteins, and cell migration and invasion. Our findings indicate that amentoflavone reduces metastatic potential through suppression of ERK and NF-κB activation in osteosarcoma U2OS cells.
Keywords: Amentoflavone; NF-κB; metastasis; nuclear factor-κB; osteosarcoma.
Copyright© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Similar articles
-
Insights Into Amentoflavone: A Natural Multifunctional Biflavonoid.Front Pharmacol. 2021 Dec 22;12:768708. doi: 10.3389/fphar.2021.768708. eCollection 2021. Front Pharmacol. 2021. PMID: 35002708 Free PMC article. Review.
-
Amentoflavone Inhibits ERK-modulated Tumor Progression in Hepatocellular Carcinoma In Vitro.In Vivo. 2018 May-Jun;32(3):549-554. doi: 10.21873/invivo.11274. In Vivo. 2018. PMID: 29695559 Free PMC article.
-
Suppression of ERK/NF-κB Activation Is Associated With Amentoflavone-Inhibited Osteosarcoma Progression In Vivo.Anticancer Res. 2019 Jul;39(7):3669-3675. doi: 10.21873/anticanres.13515. Anticancer Res. 2019. PMID: 31262893
-
Amentoflavone Induces Anti-angiogenic and Anti-metastatic Effects Through Suppression of NF-κB Activation in MCF-7 cells.Anticancer Res. 2015 Dec;35(12):6685-93. Anticancer Res. 2015. PMID: 26637885
-
Information Theory: New Look at Oncogenic Signaling Pathways.Trends Cell Biol. 2019 Nov;29(11):862-875. doi: 10.1016/j.tcb.2019.08.005. Epub 2019 Oct 17. Trends Cell Biol. 2019. PMID: 31630880 Review.
Cited by
-
Insights Into Amentoflavone: A Natural Multifunctional Biflavonoid.Front Pharmacol. 2021 Dec 22;12:768708. doi: 10.3389/fphar.2021.768708. eCollection 2021. Front Pharmacol. 2021. PMID: 35002708 Free PMC article. Review.
-
Amicis Omnia Sunt Communia: NF-κB Inhibition as an Alternative to Overcome Osteosarcoma Heterogeneity.Pharmaceuticals (Basel). 2024 Jun 5;17(6):734. doi: 10.3390/ph17060734. Pharmaceuticals (Basel). 2024. PMID: 38931401 Free PMC article. Review.
-
Circ 003390/Eukaryotic translation initiation factor 4A3 promoted cell migration and proliferation in endometrial cancer via vascular endothelial growth factor signaling by miR-195-5p.Bioengineered. 2022 May;13(5):11958-11972. doi: 10.1080/21655979.2022.2069358. Bioengineered. 2022. PMID: 35546509 Free PMC article.
-
Reinforcement of Sorafenib Anti-osteosarcoma Effect by Amentoflavone Is Associated With the Induction of Apoptosis and Inactivation of ERK/NF-κB.In Vivo. 2022 May-Jun;36(3):1136-1143. doi: 10.21873/invivo.12812. In Vivo. 2022. PMID: 35478108 Free PMC article.
-
Aurora-B Promotes Osteosarcoma Cell Growth and Metastasis Through Activation of the NPM1/ERK/NF-κβ/MMPs Axis.Cancer Manag Res. 2020 Jun 23;12:4817-4827. doi: 10.2147/CMAR.S252847. eCollection 2020. Cancer Manag Res. 2020. PMID: 32606971 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous